Literature DB >> 7690470

Two step binding of HIV-1 reverse transcriptase to nucleic acid substrates.

M Kruhøffer1, C Urbanke, F Grosse.   

Abstract

The interactions of HIV-1 reverse transcriptase (HIV-1 RT) with a synthetic 53/19-mer DNA substrate was investigated. For this template-primer HIV-1 RT displayed a Km value of 20 nM. The 53/19-mer competitively inhibited DNA synthesis performed on poly (rC).oligo(dG) with Ki value of 260 nM. This corresponded well to an equilibrium dissociation constant (Kd) of 300 nM, as determined by analytical ultracentrifugation. Since the Kd value is considerably higher than the corresponding Km value it is concluded that the enzyme--DNA complex is further stabilized by the binding of a cognate deoxynucleoside triphosphate and/or catalytic turnover. The association kinetics of HIV-1 RT with the 53/19-mer was measured by the fluorescence stopped-flow technique. RT bound the 53/19-mer with a rate constant of 2 +/- 1 x 10(8) M-1 s-1. The DNA binding step was succeeded by a concentration-independent step with a rate constant of 1.0 +/- 0.5 s-1 suggesting a conformational change of the enzyme. Template-primer binding of RT was influenced by the concentration of MgCl2, displaying a 17-fold increase in the Kd value when Mg2+ was increased from 1 mM to 30 mM. Since neither the association rate constant nor the conformational change was notably affected by changes of the Mg2+ concentration, it is concluded that the dissociation constant is increased by higher concentrations of Mg2+.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690470      PMCID: PMC309973          DOI: 10.1093/nar/21.17.3943

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase.

Authors:  M H St Clair; C A Richards; T Spector; K J Weinhold; W H Miller; A J Langlois; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

2.  Studies on the mechanism of human immunodeficiency virus reverse transcriptase. Steady-state kinetics, processivity, and polynucleotide inhibition.

Authors:  C Majumdar; J Abbotts; S Broder; S H Wilson
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

3.  Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching.

Authors:  H E Huber; J M McCoy; J S Seehra; C C Richardson
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

4.  Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide.

Authors:  C Majumdar; C A Stein; J S Cohen; S Broder; S H Wilson
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

5.  Substrate binding in human immunodeficiency virus reverse transcriptase. An analysis of pyridoxal 5'-phosphate sensitivity and identification of lysine 263 in the substrate-binding domain.

Authors:  A Basu; R S Tirumalai; M J Modak
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

6.  Reverse transcriptase from human immunodeficiency virus: a single template-primer binding site serves two physically separable catalytic functions.

Authors:  M S Krug; S L Berger
Journal:  Biochemistry       Date:  1991-11-05       Impact factor: 3.162

7.  Localization of a polynucleotide binding region in the HIV-1 reverse transcriptase: implications for primer binding.

Authors:  R W Sobol; R J Suhadolnik; A Kumar; B J Lee; D L Hatfield; S H Wilson
Journal:  Biochemistry       Date:  1991-11-05       Impact factor: 3.162

8.  Initial binding of 2'-deoxynucleoside 5'-triphosphates to human immunodeficiency virus type 1 reverse transcriptase.

Authors:  G R Painter; L L Wright; S Hopkins; P A Furman
Journal:  J Biol Chem       Date:  1991-10-15       Impact factor: 5.157

9.  Requirements for the catalysis of strand transfer synthesis by retroviral DNA polymerases.

Authors:  R G Buiser; J J DeStefano; L M Mallaber; P J Fay; R A Bambara
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

10.  Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.

Authors:  A Hizi; R Tal; M Shaharabany; S Loya
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

View more
  2 in total

1.  Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA.

Authors:  Jeffrey T Olimpo; Jeffrey J DeStefano
Journal:  Nucleic Acids Res       Date:  2010-03-24       Impact factor: 16.971

2.  Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Authors:  Grant Schauer; Sanford Leuba; Nicolas Sluis-Cremer
Journal:  Biomolecules       Date:  2013-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.